BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. - Current Ratio

The Current Ratio as of August 2026 (TTM) for BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA) is 0.88

According to BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A.’s latest financial reports and current stock price. The company's current Current Ratio is 0.88. This represents a change of -7.99% compared to the average of 0.96 of the last 4 quarters.

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA) Historical Current Ratio (quarterly & annually)

How has BML.WA Current Ratio performed in the past?

The mean historical Current Ratio of BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. over the last ten years is 1.16. The current 0.88 Current Ratio has changed 7.52% with respect to the historical average. Over the past ten years (40 quarters), BML.WA's Current Ratio was at its highest in in the December 2021 quarter at 2.38. The Current Ratio was at its lowest in in the June 2021 quarter at 0.

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA) Average Current Ratio

How has BML.WA Current Ratio performed in the past?

The current Current Ratio of BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA) Current Ratio vs. Peers

How is BML.WA’s Current Ratio compared to its peers?

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A.’s Current Ratio is less than KGHM Polska Miedz S.A. (1.27), less than Allegro.eu S.A. (1.66), less than Polski Koncern Naftowy ORLEN Spólka Akcyjna (1.35), greater than Powszechny Zaklad Ubezpieczen S.A. (0.37), less than CD Projekt S.A. (6.01),

Build a custom stock screener for BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.